CRISPR Therapeutics AG
ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR

Last updated:

Abstract:

High affinity antibodies capable of binding to a single-chain variable fragment (scFv) of anti-BCMA antibody, for example, the scFv expressed on cell surface as a portion of a chimeric antigen receptor (CAR). Also provided herein are methods for producing such anti-scFv antibodies and methods of using the antibodies disclosed herein for detecting, for example, T cells expressing an anti-BCMA CAR that comprise the scFv as an extracellular domain.

Status:
Application
Type:

Utility

Filling date:

23 Aug 2021

Issue date:

3 Mar 2022